Strong Tower Advisory Services - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Strong Tower Advisory Services ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$34,000
-24.4%
10,650
-10.1%
0.02%
-16.7%
Q2 2022$45,000
-55.0%
11,850
-36.1%
0.02%
-52.9%
Q1 2022$100,000
-98.4%
18,550
-95.9%
0.05%
-98.4%
Q4 2021$6,118,000
-11.5%
452,879
+11.8%
3.26%
-19.0%
Q3 2021$6,913,000404,9724.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$82,950,0002.19%
MAVERICK CAPITAL LTD 5,678,221$94,202,0001.75%
Rhenman & Partners Asset Management AB 1,000,000$16,590,0001.48%
Goodman Financial Corp 119,198$1,977,0000.92%
Bellevue Group AG 3,632,358$60,261,0000.83%
OSTERWEIS CAPITAL MANAGEMENT INC 477,004$7,914,0000.53%
Parametrica Management Ltd 13,658$226,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 592,930$9,837,0000.40%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 67,000$1,110,0000.36%
Burleson & Company, LLC 92,836$1,617,0000.31%
View complete list of NEKTAR THERAPEUTICS shareholders